Purple Biotech Ltd. (NASDAQ: PPBT)
$2.5900
+0.0500 ( +4.44% ) 38.7K
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Market Data
Open
$2.5900
Previous close
$2.5400
Volume
38.7K
Market cap
$3.98M
Day range
$2.4800 - $2.7900
52 week range
$2.4000 - $23.2000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 54 | Jun 04, 2024 |
| 6-k | Form 6-K | 3 | Jun 03, 2024 |
| 6-k | Form 6-K | 2 | May 21, 2024 |
| 6-k | Form 6-K | 46 | May 02, 2024 |
| 6-k | Form 6-K | 2 | Apr 25, 2024 |
| 6-k | Form 6-K | 2 | Mar 28, 2024 |
| 6-k | Form 6-K | 2 | Mar 14, 2024 |
| 6-k | Form 6-K | 45 | Mar 06, 2024 |
| 20-f | Annual reports | 110 | Mar 05, 2024 |
| 6-k | Form 6-K | 2 | Mar 05, 2024 |